Orange Book product · Generic (ANDA)
NIMODIPINE
NIMODIPINE
At a glance
Jul 09, 2024
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 09, 2024
2 yr ago
Today
Pharmaceutical detail
Active ingredient
NIMODIPINE
Strength
3MG/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 216937
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of NIMODIPINE
- 2013NYMALIZEBrand (NDA)
NDA 203340 · AZURITY
- 1988NIMOTOPBrand (NDA)
NDA 018869 · BAYER PHARMS
- 2025NIMODIPINEGeneric (ANDA)
ANDA 213409 · ALKEM LABS LTD
- 2015NIMODIPINEGeneric (ANDA)
ANDA 201832 · SOFGEN PHARMS
- 2014NIMODIPINEGeneric (ANDA)
ANDA 090103 · THEPHARMANETWORK LLC
- 2008NIMODIPINEGeneric (ANDA)
ANDA 076740 · BIONPHARMA
- 2007NIMODIPINEGeneric (ANDA)
ANDA 077811 · HERITAGE
- 2007NIMODIPINEGeneric (ANDA)
ANDA 077067 · SUN PHARM INDS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
